Telix Pharmaceuticals Ltd (TLX) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Telix Pharmaceuticals Ltd  (NASDAQ: TLX)
 

Telix Pharmaceuticals Ltd Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TLX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 2.65 % 12.12 % 7.69 % 5.68 %
Q / Q Revenue Growth (Q4 MRQ) - 3.94 % 3.27 % 2.63 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 2.65 % 7.48 % 5.74 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) - 4.08 % 2.39 % 1.74 %
Revenue 5 Year Average Growth - 15.58 % 11.69 % 9.77 %


TLX's Growth Comparisons in IV. Quarter 2025




Telix Pharmaceuticals Ltd's Revenue slowed to the 2.65% year on year, improvement in the fourth quarter 2025 to 803 millions, underperforming the 12.12% rise in the Major Pharmaceutical Preparations industry and 7.69% Revenue growth in the Healthcare sector. Although both, the Major Pharmaceutical Preparations industry and the Healthcare sector posted higher gains than 5.68% overall market increase, Telix Pharmaceuticals Ltd was trailing overall market in the fourth quarter.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2025 earnings reports, average yearly sales growth is 9.77%.

TLX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
segments
-
-
Precision Medicine
-
-
Therapeutics
-
-
Manufacturing Solutions
-
-
Inter-eliminations
-
-
China
-
-
United States
-
-
Other countries
-
-
At a point in time Precision Medicine
-
-
At a point in time Manufacturing Solutions
-
-
At a point in time Therapeutics
-
-
Over time Manufacturing Solutions
-
-
Over time Therapeutics
-
-
Total
-
-


Growth Rates of TLX's Income in the fourth quarter 2025


TLX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -63.75 % 155.5 % 43.36 % -0.27 %
Sequential Operating Income Change (Q4 MRQ) - -35.64 % -22.05 % -8.98 %
Y / Y Operating Income Growth (Q4 TTM) -63.75 % 18.81 % 19.61 % 9.24 %
Sequential Operating Income Growth (Q4 TTM) -63.75 % 15.12 % 7.78 % -0.22 %
Operating Income 5 Year Avg. Change - 2.08 % 0.04 % 17.16 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - - -97.24 % 22.99 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - - -95.98 % 8.13 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 3.72 % 9.35 % 11.58 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - -3.53 % -5.92 % 4.61 %
Income from Cont. Ops. 5 Year Avg. Change - -0.36 % -5.93 % 17.27 %

TLX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 128.53 % 37.76 % 25.85 %
Q / Q Net Income Growth (Q4 MRQ) - 19.99 % -20.76 % 7.59 %
Y / Y Net Income Change (Q4 TTM) - -18.88 % -9.02 % 9.66 %
Sequential Net Income Change (Q4 TTM) - -3.09 % -6.02 % 5.18 %
Net Income 5 Year Avg. Growth - 16.73 % 7.4 % 16.77 %

TLX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - - -97.24 % 22.99 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - - -95.98 % 8.13 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - 33 %
EPS from Cont. Ops. 5 Year Avg. Growth - -15.45 % -5.93 % 17.27 %



TLX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 90.85 % 37.76 % 17.27 %
Q / Q EPS Net Growth (Q4 MRQ) - 30.6 % -20.76 % 7.59 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 92.65 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - 33 %
EPS Net 5 Year Avg. Change - 16.73 % 7.4 % 16.77 %



Telix Pharmaceuticals Ltd reported bottom-line of $ 0.00 in the fourth quarter, compare to $ 0.00 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 90.85%, while Healthcare sector increased by 37.76%, and overall market improved by 25.85%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2025 financial results, average yearly income per share growth is 16.77%.

TLX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 56.99 % 49.29 % 32.85 %
Sequential Free Cash Flow Change (Q4 MRQ) - -24.26 % -6.05 % 113.08 %
Y / Y Free Cash Flow Change (Q4 TTM) - 96.5 % 72.27 % 10.44 %
Sequential Free Cash Flow Change (Q4 TTM) - 80.96 % 57.27 % 9.43 %
Free Cash Flow 5 Year Avg. Change - 15.66 % 10.64 % 18.09 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - -82.47 % - -81.15 %
Sequential Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) - 198.68 % 173.42 % -
Sequential Net Cash Flow Change (Q4 TTM) - 15908 % - -
Net Cash Flow 5 Year Avg. Change - -4.78 % 0.82 % -29.23 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 181.8 % 3.32 % 11.12 % 22.34 %
Sequential Capital Expenditures Change (Q4 MRQ) - 26.08 % 20.75 % 17.09 %
Y / Y Capital Expenditures Change (Q4 TTM) 181.8 % 24.06 % 16.17 % 41.57 %
Sequential Capital Expenditures Change (Q4 TTM) 181.8 % 20.81 % 14.03 % 6.83 %
Capital Expenditures 5 Year Avg. Change - 10.97 % 9.12 % 10.29 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.